Stock 600079 HUMANWELL HEALTHCARE (GROUP) CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Humanwell Healthcare (Group) Co.,Ltd.

Equities

600079

CNE000000QW6

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 12/05/2024 BST 		5-day change 1st Jan Change
20.46 CNY -0.97% Intraday chart for Humanwell Healthcare (Group) Co.,Ltd. +1.04% -17.70%
07:38am Humanwell Healthcare's Unit Gets Nod to Strengthen Oxycodone Hydrochloride Tablets' Dosage MT
04-30 Humanwell Healthcare's Q1 Profit Falls 27% MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Humanwell Healthcare's Unit Gets Nod to Strengthen Oxycodone Hydrochloride Tablets' Dosage
MT
Humanwell Healthcare's Q1 Profit Falls 27%
MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Humanwell Healthcare's Profit Drops, Operating Income Climbs in 2023
MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Humanwell Healthcare's Subsidiary Gets Nod to Register Idecalcidol Soft Capsules
MT
Production Line of Humanwell Healthcare's Unit Passes UK Drug Regulator's Inspection
MT
Humanwell Healthcare Co.,Ltd. completed the acquisition of essential business operations of PAION AG and PAION Deutschland GmbH.
CI
Humanwell Healthcare's Subsidiary Gets Nod to Register Anesthesia Drug
MT
Humanwell Healthcare's Unit Enters Phase II Trial of Gout Drug
MT
Humanwell Unit Gets China Registration Certificate for Drug to Prevent Renal Allograft Rejection
MT
Humanwell Healthcare Co.,Ltd. signed an agreement essential business operations of PAION AG and PAION Deutschland GmbH.
CI
Humanwell Healthcare's Unit Gets Nod for Registration of Acetaminophen Mannitol Injection
MT
Humanwell Healthcare's Unit to Trial Naltrexone Bromide Tablets
MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Humanwell Healthcare's Unit Gets Nod to Trial HZ-J001 Cream
MT
Humanwell Healthcare Completes Transfer of Huatai Insurance Stake
MT
Humanwell Healthcare Unit Gets Registration Certificate for Azithromycin Dry Suspension
MT
Humanwell Healthcare's Unit Gets Nod to Trial HWH486 Capsules
MT
Humanwell Healthcare Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600079 Stock
  4. News Humanwell Healthcare (Group) Co.,Ltd.
  5. Highlights